Evidence map›Paper›PMID 35528276›Full record

ArticleMedicina intensiva2023

Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study.

C Levy, N Dognon, S Normandin, T Duburcq, A Gaudet, Lille Intensive Care COVID-19 group, Lille Intensive Care COVID-19 group, Erika Parmentier-Decrucq, Julien Poissy, Sylvain Dubucquoi and 30 more

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina intensiva, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 4 institutions in 1 country.

C LevyDepartment of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
N DognonDepartment of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
S NormandinDepartment of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
T DuburcqDepartment of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
A GaudetDepartment of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
Lille Intensive Care COVID-19 group
Lille Intensive Care COVID-19 group
Erika Parmentier-Decrucq
Julien Poissy
Sylvain Dubucquoi
Pauline Boddaert
Morgan Caplan
Julien Goutay
Arthur Durand
Benoit Graffin
Myrtille Gaudel
Charles Detollenaere
Ines Gueguen
Marine Van Ceunebroek
Romain Tortuyaux
Ouriel Saura
Ahmed El Kalioubie
Raphael Favory
Patrick Girardie
Marion Houard
Emmanuelle Jaillette
Mercedes Jourdain
Geoffrey Ledoux
Daniel Mathieu
Anne Sophie Moreau
Saad Nseir
Thierry Onimus
Sebastien Preau
Laurent Robriquet
Anahita Rouze
Sophie Six
Jerome Soquet
Valentin Loobuyck
Agnes Mugnier
André Vincentelli
Centre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire de Lille · FRInserm · FRLille Inflammation Research International Center · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35528276
PMCPMC9068658
OpenAlexW4229079430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.